SCHEMBL5408873

SCHEMBL5408873

CCCCC(C#N)CO

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28653199 1.00
SCHEMBL18923179 1.00
SCHEMBL10975596 0.91 LMNA (0.54)
SCHEMBL8956889 0.87
SCHEMBL3804825 0.87
SCHEMBL3677002 0.84 TSHR (0.50)
SCHEMBL3671291 0.79
SCHEMBL9228631 0.79
SCHEMBL10155552 0.79 TSHR (0.46)
SCHEMBL3673710 0.79 TSHR (0.46)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 35 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0260910-B1 3,6-DIPHENYLPYRIDAZINES Chisso Corporation (JP) 1992-05-27 EP claimed
CN-103214483-B Heteroaryl substituted pyrrolo[2,3-b]pyridines and pyrrolo[2,3-b]pyrimidines as janus kinase inhibitors INCYTE CORP 2014-12-17 CN disclosed
CN-103254190-A Heteroaryl substituted pyrrolo[2,3-b]pyridines and pyrrolo[2,3-b]pyrimidines as janus kinase inhibitors INCYTE CORP 2013-08-21 CN disclosed
CN-103214483-A Heteroaryl substituted pyrrolo[2,3-b]pyridines and pyrrolo[2,3-b]pyrimidines as janus kinase inhibitors INCYTE CORP 2013-07-24 CN disclosed
CN-103214484-A Heteroaryl substituted pyrrolo[2,3-b]pyridines and pyrrolo[2,3-b]pyrimidines as janus kinase inhibitors INCYTE CORP A DELAWARE CORP 2013-07-24 CN disclosed
CN-101448826-A Heteroaryl substituted pyrrolo [2 ] as janus kinase inhibitors INCYTE CORP (US) 2009-06-03 CN disclosed
US-7199147-B2 Rho kinase inhibitors DAINIPPON SUMITOMO PHARMA CO., LTD. (JP) 2007-04-03 US disclosed
US-20040138286-A1 Rho kinase inhibitors DAINIPPON SUMITOMO PHARMA CO., LTD. (JP) 2004-07-15 US disclosed
EP-1403255-A1 Rho KINASE INHIBITORS SUMITOMO PHARMACEUTICALS COMPANY, LIMITED (JP) 2004-03-31 EP disclosed
US-5637255-A OPTICALLY ACTIVE FORM, USED FOR OPTICAL OR ELECTROOPTICAL DISPLYING; HIGH TWISTING; DOPANT ROLIC AG (CH) 1997-06-10 US disclosed
EP-0441213-A2 Chiral dioxolanes F. HOFFMANN-LA ROCHE AG (CH) 1991-08-14 EP disclosed
US-5032312-A Liquid crystals HOFFMANN-LA ROCHE INC. (US) 1991-07-16 US disclosed
EP-0410233-A2 (4-Arylbutyl) cyclohexane derivatives F. HOFFMANN-LA ROCHE AG (CH) 1991-01-30 EP disclosed
EP-0393501-A1 Liquid crystal components with a trans-3-cyclohexylallyloxy group F. HOFFMANN-LA ROCHE AG (CH) 1990-10-24 EP disclosed
US-4818430-A LIQUID CRYSTALS CHISSO CORPORATION (JP) 1989-04-04 US disclosed
EP-0260910-A1 3,6-Diphenylpyridazines Chisso Corporation (JP) 1988-03-23 EP disclosed
US-4626560-A Novel binding agent compositions, foundry sand compositions and ureido functional organosilicon compounds UNION CARBIDE CORPORATION (US) 1986-12-02 US disclosed
EP-0077036-B1 BINDING AGENT COMPOSITIONS UNION CARBIDE CORPORATION (US) 1986-01-08 EP disclosed
EP-0077036-A1 Binding agent compositions UNION CARBIDE CORPORATION (US) 1983-04-20 EP disclosed
US-4046794-A ANCHORING AGENTS ON GLASS UNION CARBIDE CORPORATION (US) 1977-09-06 US disclosed